C12N 2710/10251
Methods of production or purification of viral material
C12N2710/10251 (Methods of production or purification of viral material) appears on 9 US grants and 10 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 10
- Assignees
- 11
- Inventors
- 21
- Latest grant
- 10 May 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 3 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 2 | 1 |
| 2016 | 2 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Vaccines for inclusion body hepatitis10 May 2016US 9,333,253 B2University of Guelph
- Avian adenoassociated virus and uses thereof19 Jan 2016US 9,238,800 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Immortalized avian cell lines for virus production27 Jan 2015US 8,940,534 B2Probiogen AG
- Avian adenoassociated virus and uses thereof6 Jan 2015US 8,927,269 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Vaccines for inclusion body hepatitis3 Sep 2013US 8,524,249 B2University of Guelph
- Replication-deficient avian adenoviral vectors, their design and uses11 May 2023US 2023/0140994 A1Greffex, Inc.
- Stabilized non-enveloped virus compositions31 Mar 2022US 2022/0096375 A1Ziccum AB
- Avian Adenoassociated Virus and Uses Thereof4 Jun 2015US 2015/0152393 A1The USA, as represented by the Secretary, Dept. of Health and Human Services
- Vaccines for inclusion body hepatitis7 Nov 2013US 2013/0295126 A1University of Guelph
- Immortalized avian cell lines for virus production15 Nov 2012US 2012/0288916 A1Probiogen AG
Most cited
By later US patents
- Composition for introducing nucleic acid complexes into higher eucaryotic cells257US 5,547,932 ABoehringer Ingelheim International GmbH · 1996
- Avian adenoassociated virus and uses thereof41US 9,238,800 B2The United States of America, as represented by the Secretary, Department of Health and Human Services · 2016
- Composition for introducing nucleic acid complexes into higher eucaryotic cells34US 6,022,735 ABoehringer Ingelheim International GmbH · 2000
- Composition for introducing nucleic acid complexes into higher eucaryotic cells27US 6,274,322 B1Boehringer Ingelheim International GmbH · 2001
- Composition for introducing nucleic acid complexes into higher eucaryotic cells25US 6,077,663 ABoehringer Ingelheim International GmbH · 2000